Author details

Full Name

Paul Emery

Affiliation

ORCID

Career Start Year

1981

Papers

1126

H Index

148

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36526336	Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis.		2023
35699062	Can biomarkers predict successful tapering of conventional disease-modifying therapy in rheumatoid arthritis patients in stable remission?	Clinical and Experimental Rheumatology	2023
35819806	Association of circulating lymphocyte subsets with response to IL17i and TNFi in axial spondyloarthritis.	Clinical and Experimental Rheumatology	2023
36082459	No differences in myocardial perfusion between treatment-naive, early rheumatoid arthritis patients and healthy controls.	Arthritis and Rheumatology	2023
36409591	Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry-Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus.	Arthritis and Rheumatology	2023
37607810	Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?		2023
37676828	Lymphocyte subset phenotyping for the prediction of progression to inflammatory arthritis in anti-citrullinated-peptide antibody-positive at-risk individuals.		2023
37601773	Antibodies to leukotoxin A from the periodontal pathogen in patients at an increased risk of rheumatoid arthritis.		2023
37934127	Ultrasound in anti-CCP+ at-risk individuals without clinical synovitis: development of a novel 6-joint protocol for feasible risk prediction.		2023
37830590	DNA Hypomethylation in the TNF-Alpha Gene Predicts Rheumatoid Arthritis Classification in Patients with Early Inflammatory Symptoms.		2023
37991554	Whole-body MRI for the investigation of joint involvement in inflammatory arthritis.		2023
37714552	Ultrasound in the Management of Patients With Psoriatic Arthritis: Systematic Literature Review and Novel Algorithms for Pragmatic Use.		2023
38073013	Serum and tissue biomarkers associated with CRESS and STAR response to B-cell targeted therapy in TRACTISS trial of Sjogren's syndrome.		2023
37701927	Preclinical/subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences.	Lancet Rheumatol	2023
38059326	Poly-refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease with Distinct Inflammatory and Non-inflammatory Phenotypes.		2023
38057656	Filgotinib Demonstrates Efficacy in Rheumatoid Arthritis Independent of Smoking Status: Post Hoc Analysis of Phase 3 Trials and Claims-Based Analysis.		2023
37087459	The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study.		2023
36712951	Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.		2023
37195941	A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis.		2023
36869251	Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis.		2023
37061234	Factors Associated With Maintenance of Remission Following Change From Combination Therapy to Monotherapy in Patients With Rheumatoid Arthritis.		2023
36997210	Opportunities and challenges in early diagnosis of rheumatoid arthritis in general practice.		2023
36459119	Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA Trial.	Journal of Clinical Rheumatology	2023
37523695	Predicting Inflammatory Arthritis in At-Risk Persons: Development of Scores for Risk Stratification.		2023
37507209	Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review.		2023
37494493	Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis. Reply.		2023
34750103	Perceptions and experiences of individuals at-risk of rheumatoid arthritis (RA) knowing about their risk of developing RA and being offered preventive treatment: systematic review and thematic synthesis of qualitative studies.	Annals of the Rheumatic Diseases	2022
36371989	Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity.	EBioMedicine	2022
35640490	Critical appraisal and future outlook on anti-inflammatory biosimilar use in chronic immune-mediated inflammatory diseases.	Seminars in Arthritis and Rheumatism	2022
35937776	Single-centre experience of refractory rheumatoid arthritis.	Rheumatology Advances in Practice	2022
35365569	Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses.	RMD Open	2022
35666029	Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary SjÃ¶gren Syndrome.	ACR Open Rheumatology	2022
36585217	Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis.		2022
36535711	Added value of multiple autoantibody testing for predicting progression to inflammatory arthritis in at-risk individuals.		2022
36526722	IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma.	Nat Med	2022
34285049	Determining in which pre-arthritis stage HLA-shared epitope alleles and smoking exert their effect on the development of rheumatoid arthritis.	Ann Rheum Dis	2022
32513649	Response to: 'Pisotriquetral arthritis: 'forgotten' joint in ultrasound imaging of the wrist' by Becciolini .	Annals of the Rheumatic Diseases	2022
35042555	Prioritising referrals of individuals at-risk of RA: guidance based on results of a 10-year national primary care observational study.		2022
34571001	Nailfold Microvascular Imaging by Dynamic Optical Coherence Tomography in Systemic Sclerosis: A Case-Controlled Pilot Study.		2022
34902228	Toward Individualized Prediction of Response to Methotrexate in Early Rheumatoid Arthritis: A Pharmacogenomics-Driven Machine Learning Approach.	Arthritis Care Res (Hoboken)	2022
34849610	Ultrasound subclinical synovitis in anti-CCP-positive at-risk individuals with musculoskeletal symptoms: an important and predictable stage in the rheumatoid arthritis continuum.	Rheumatology	2022
34664622	Efficacy of tumour-necrosis factor-inhibitor in moderate disease activity rheumatoid arthritis: sub-analysis of the 'VEDERA' trial.	Rheumatology	2022
35172859	Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept.		2022
34893470	Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis.	Annals of the Rheumatic Diseases	2022
35177322	Repeatability of quantitative MRI in patients with rheumatoid arthritis.	Radiography	2022
35136863	COVID-19 vaccine-induced T-cell responses in patients with rheumatoid arthritis: preferential induction by ChAdOx1.	Lancet Rheumatology, The	2022
35284780	Ultrasound shows swollen joints are the better proxy for synovitis than tender joints in DMARD-naÃ¯ve early psoriatic arthritis.	Rheumatology Advances in Practice	2021
33792659	Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study.	Rheumatology	2021
33938140	Should we aim for personalized prevention in individuals at risk of rheumatoid arthritis?	International Journal of Rheumatic Diseases	2021
33769258	Interleukin-7: a potential factor supporting B-cell maturation in the rheumatoid arthritis synovium.	Clinical and Experimental Rheumatology	2021